Valuation: Abbott Laboratories

Market Cap 167B 149B 139B 127B 238B 16,109B 242B 1,681B 651B 8,204B 628B 615B 26,350B P/E 2026 *
27.4x
P/E 2027 * 21.2x
Enterprise Value 191B 170B 159B 145B 273B 18,414B 276B 1,922B 744B 9,378B 718B 702B 30,121B EV / Sales 2026 *
3.81x
EV / Sales 2027 * 3.45x
Free-Float
86.16%
Yield 2026 *
2.66%
Yield 2027 * 2.83%
1 day-2.17%
1 week-4.33%
Current month-2.17%
1 month-11.24%
3 months+4.89%
6 months-5.56%
Current year-22.83%
1 week 96.54
Extreme 96.54
101.76
1 month 96.54
Extreme 96.54
112
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
135.36
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
23/09/26 Tax

Director

-52,507 0.0030%
02/09/26 Sell

Controller/Auditor

-27 0.0000%
01/09/26 Tax

Chief Financial Officer

-388 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.17%-4.33%-27.56%-0.17% 167B
+0.17%-2.34%-8.83%+10.31% 111B
-0.88%+1.19%-25.04%-0.11% 105B
+0.21%+0.76%-48.25%-11.40% 74.82B
+3.17%-0.03%-0.64%+72.13% 59.11B
-0.86%+2.96%+13.57%+59.50% 51.8B
-0.52%-0.65%-6.74%-31.12% 48.5B
-0.85%+0.85%-16.51%+18.41% 40.79B
-0.07%-1.42%+30.49%-7.58% 32.54B
+0.32%-0.49%-11.51%-23.81% 30.76B
Average -0.14%-0.23%-10.10%+8.61% 72.09B
Weighted average by Cap. -0.45%-0.91%-15.97%+8.12%

Financials

2026 *2027 *
Net sales 50.21B 44.59B 41.7B 38B 71.55B 4,834B 72.53B 505B 195B 2,462B 189B 184B 7,907B 54.53B 48.43B 45.29B 41.27B 77.71B 5,250B 78.77B 548B 212B 2,674B 205B 200B 8,588B
Net income 6.3B 5.6B 5.24B 4.77B 8.98B 607B 9.11B 63.34B 24.52B 309B 23.67B 23.15B 993B 7.98B 7.09B 6.63B 6.04B 11.37B 768B 11.52B 80.16B 31.03B 391B 29.95B 29.3B 1,256B
Net Debt 23.94B 21.26B 19.88B 18.12B 34.11B 2,305B 34.58B 241B 93.12B 1,174B 89.88B 87.93B 3,770B 20.96B 18.61B 17.41B 15.86B 29.86B 2,018B 30.27B 211B 81.52B 1,028B 78.68B 76.98B 3,301B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
01/10/26 $96.69 -2.17% 8,862,865
30/09/26 $98.83 -2.10% 7,571,495
29/09/26 $100.95 -0.03% 8,049,113
28/09/26 $100.98 -0.31% 6,802,510
25/09/26 $101.29 +0.22% 7,784,309
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
96.69USD
Average target price
120.26USD
Spread / Average Target
+24.38%

Quarterly revenue - Rate of surprise